Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
bimzelx
ucb pharma s.a. - bimekizumab - psoriāze - imūnsupresanti - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.
Latvija -
latviešu -
Zāļu valsts aģentūra
aritavi 30 mg zarnās šķīstošās cietās kapsulas
actavis group ptc ehf., iceland - duloksetīns - zarnās šķīstošās cietās kapsulas - 30 mg
Latvija -
latviešu -
Zāļu valsts aģentūra
aritavi 60 mg zarnās šķīstošās cietās kapsulas
actavis group ptc ehf., iceland - duloksetīns - zarnās šķīstošās cietās kapsulas - 60 mg
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
kaftrio
vertex pharmaceuticals (ireland) limited - ivacaftor, tezacaftor, elexacaftor - cistiskā fibroze - other respiratory system products - kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.
Eiropas Savienība -
latviešu -
EMA (European Medicines Agency)
cablivi
ablynx nv - caplacizumab - sarkanguļu, trombozes trombocitopēniska - antitrombotiskie līdzekļi - cablivi ir indicēts, lai ārstētu pieaugušos piedzīvo epizode iegūto trombozes trombocitopēniska purpura (attp), kopā ar plazmas apmaiņa un immunosuppression.
Latvija -
latviešu -
Zāļu valsts aģentūra
climara 50 mikrogramu/24 stundās transdermāls plāksteris
bayer ag, germany - estradiols - transdermāls plāksteris - 3,8 mg
Latvija -
latviešu -
Ecolab
01-sizzle plus heat-activated grill toaster cleaner
ecolab deutschland gmbh -